InfuSystems Holdings Inc. (INFU) exhibits 56.0% gross margins and 12.8% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 24.5x enterprise multiple and 4.8% implied options volatility.
Sustained 56.0% gross profitability converts into 8.3% operating margin and 12.8% ROIC, outpacing sector cost of capital.
ROIC: 12.8% // GM: 56.0%YoY revenue trajectory of +6.4% paired with 8.29% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +6.4% // FCF YLD: 8.29%Altman Z-Score of 5.16 and Piotroski F-Score of 9/9 indicate low near-term refinancing stress.
ALTMAN Z: 5.16 // F-SCORE: 9/9Trading at 43.4x trailing P/E (40.4x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 43.4x // EV/EBITDA: 24.5xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $14.45 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend 4.6% net margins.
NET MARGIN: 4.6% // D/E: 0.34x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for INFU & activate live FRED threshold breach alerts.